The Business Times

Europe: Industrials help shares shrug off China data

Published Mon, Jul 16, 2018 · 07:59 AM
Share this article.

[LONDON] Strong industrials and pharma stocks helped European shares make hesitant gains on Monday while data showing slowing economic growth from China kept a lid on the market's progress.

The pan-European STOXX 600 inched up 0.2 per cent by 0725 GMT, in line with Germany's DAX, which is heavily exposed to China.

Basic resources and autos were among the worst-performing sectors as they are both reliant on solid Chinese growth, but industrials merger speculation helped outweigh the overall negative impact of the data.

The top European mover was drugmaker Indivior, jumping 26 per cent after a US court blocked India's Dr Reddy's Laboratories from selling generic versions of its bestselling opioid addiction treatment in the US.

Elevator firm Kone drove gains among industrials, with a 1.7 per cent gain after a report that the Finnish company and Germany's Thyssenkrupp had held merger talks on their elevator operations. Thyssenkrupp rose 0.8 per cent.

Shares in French technology consultancy firm Altran climbed 3.8 per cent after Friday's 30 per cent plunge on the discovery of forged orders at its recently acquired US business Aricent.

Broker recommendations also moved some stocks.

French publisher Lagardere rose 4.2 per cent after Morgan Stanley upgraded it to overweight, while British software firm Micro Focus fell 4 per cent after a Credit Suisse downgrade to underweight.

In the UK market, Debenhams shares fell 5.6 per cent after a Sunday Times report said credit insurers had cut cover for suppliers to the department store, which has issued three profit warnings this year.

REUTERS

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Capital Markets & Currencies

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here